Cargando…
Repositioning linifanib as a potent anti-necroptosis agent for sepsis
Sepsis is a systemic inflammatory syndrome (SIRS) caused by acute microbial infection, and it has an extremely high mortality rate. Tumor necrosis factor-α (TNF-α)-induced necroptosis contributes to the pathophysiology of sepsis, so inhibiting necroptosis might be expected to improve clinical outcom...
Autores principales: | Yu, Liang, Yang, Kai, He, Xiaoyan, Li, Min, Gao, Lin, Zha, Yunhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913023/ https://www.ncbi.nlm.nih.gov/pubmed/36765040 http://dx.doi.org/10.1038/s41420-023-01351-y |
Ejemplares similares
-
Linifanib
Publicado: (2012) -
Identification of Piperlongumine as Potent Inhibitor of Necroptosis
por: He, Xiaoyan, et al.
Publicado: (2023) -
Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib
por: Pan, Hongming, et al.
Publicado: (2014) -
LINCS L1000 dataset-based repositioning of CGP-60474 as a highly potent anti-endotoxemic agent
por: Han, Hyun-Wook, et al.
Publicado: (2018) -
Author Correction: Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib
por: Pan, Hongming, et al.
Publicado: (2020)